Valion Bio (VBIO) EBT Margin (2021 - 2026)
Valion Bio (VBIO) posted quarterly EBT Margin of 91.25% for Q4 2025, up 93014.0% year-over-year from N/an in Q4 2024, and up 105.37% quarter-over-quarter from 1697.95% in Q3 2025.
Valion Bio (VBIO) EBT Margin (2021 - 2026) Analysis & Trends
Valion Bio's EBT Margin history runs 5 years deep, the most recent figure standing at 91.25% for Q4 2025.
- In Q4 2025, EBT Margin rose 93014.0% year-over-year to 91.25%; the TTM figure through Dec 2025 stood at 1530.37% (down 78690.0% YoY), while the FY2025 annual figure was 78.8%, up 67197.0% from the prior year.
- EBT Margin for Q4 2025 stood at 91.25%, up from 1697.95% in the prior quarter.
- The five-year high for EBT Margin was 91.25% in Q4 2025, with the low at 2248.84% in Q2 2025.
- The 5-year median for EBT Margin is 593.78% (2022), against an average of 841.38%.
- Peak annual rise in EBT Margin reached 93014 bps in 2025, while the deepest fall reached 169275 bps in 2025.
- Valion Bio's EBT Margin stood at 589.2% in 2021, then increased by 4 bps to 565.44% in 2022, then decreased by 14 bps to 643.14% in 2023, then slumped by 30 bps to 838.89% in 2024, then jumped by 111 bps to 91.25% in 2025.
- Business Quant data shows VBIO's EBT Margin at 91.25% in Q4 2025, 1697.95% in Q3 2025, and 2248.84% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 41.75% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 35.61% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 35.71% |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -528.97% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 18.33% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 13.77% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -25.06% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -2.67% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 12.09% |
| 10 | Valion Bio | 405,599.63 | -1.79 Mn | -45,000.00 | -115.38% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -40,038.46% |
| Dec 31, 2025 | 91.25% |
| Sep 30, 2025 | -1,697.95% |
| Jun 30, 2025 | -2,248.84% |
| Mar 31, 2025 | -2,151.43% |
| Dec 31, 2024 | -838.89% |
| Sep 30, 2024 | -1,135.71% |
| Jun 30, 2024 | -947.14% |
| Mar 31, 2024 | -458.68% |
| Dec 31, 2023 | -643.14% |
| Sep 30, 2023 | -642.20% |
| Jun 30, 2023 | -1,352.17% |
| Mar 31, 2023 | -576.06% |
| Dec 31, 2022 | -565.44% |
| Sep 30, 2022 | -552.20% |
| Jun 30, 2022 | -581.06% |
| Mar 31, 2022 | -598.36% |
| Dec 31, 2021 | -589.20% |
| Sep 30, 2021 | -443.68% |
| Jun 30, 2021 | -476.87% |